[{"address1": "11682 El Camino Real", "address2": "Suite 120", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 771 9307", "website": "https://ars-pharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for the emergency treatment of Type I allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.", "fullTimeEmployees": 24, "companyOfficers": [{"maxAge": 1, "name": "Mr. Richard  Lowenthal M.B.A., M.S., MSMSEL", "age": 57, "title": "Founder, President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": 908829, "exercisedValue": 0, "unexercisedValue": 3493696}, {"maxAge": 1, "name": "Dr. Sarina  Tanimoto M.B.A., M.D.", "age": 55, "title": "Co-Founder & Chief Medical Officer", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": 748972, "exercisedValue": 0, "unexercisedValue": 1222794}, {"maxAge": 1, "name": "Mr. Eric  Karas", "age": 51, "title": "Chief Commercial Officer", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": 618614, "exercisedValue": 0, "unexercisedValue": 4320554}, {"maxAge": 1, "name": "Dr. Robert  Bell Ph.D.", "title": "Co-Founder & Chief Science Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kathleen D. Scott CPA", "title": "Chief Financial Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian T. Dorsey M.S.", "age": 54, "title": "Chief Operations Officer", "yearBorn": 1969, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alexander A. Fitzpatrick Esq.", "age": 56, "title": "Chief Legal Officer & Secretary", "yearBorn": 1967, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Relovsky", "title": "Senior Vice President of Marketing", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Harris  Kaplan M.B.A.", "age": 71, "title": "Executive Vice President of Commercial Strategy", "yearBorn": 1952, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Justin  Chakma", "age": 33, "title": "Chief Business Officer & Secretary", "yearBorn": 1990, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 10, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1709251200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 10.22, "open": 10.2, "dayLow": 9.405, "dayHigh": 10.2, "regularMarketPreviousClose": 10.22, "regularMarketOpen": 10.2, "regularMarketDayLow": 9.405, "regularMarketDayHigh": 10.2, "forwardPE": -17.867926, "volume": 722963, "regularMarketVolume": 722963, "averageVolume": 639163, "averageVolume10days": 1334690, "averageDailyVolume10Day": 1334690, "marketCap": 913870208, "fiftyTwoWeekLow": 2.55, "fiftyTwoWeekHigh": 11.27, "priceToSalesTrailing12Months": 30462.34, "fiftyDayAverage": 7.8155, "twoHundredDayAverage": 6.135275, "currency": "USD", "enterpriseValue": 733069504, "floatShares": 36836573, "sharesOutstanding": 96501600, "sharesShort": 4254773, "sharesShortPriorMonth": 4862439, "sharesShortPreviousMonthDate": 1707955200, "dateShortInterest": 1710460800, "sharesPercentSharesOut": 0.044099998, "heldPercentInsiders": 0.27547002, "heldPercentInstitutions": 0.68095, "shortRatio": 5.03, "shortPercentOfFloat": 0.0709, "impliedSharesOutstanding": 95997296, "bookValue": 2.393, "priceToBook": 3.957376, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -54365000, "trailingEps": -0.57, "forwardEps": -0.53, "enterpriseToRevenue": 24435.648, "enterpriseToEbitda": -10.869, "52WeekChange": 0.7380953, "SandP52WeekChange": 0.28136122, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "SPRY", "underlyingSymbol": "SPRY", "shortName": "ARS Pharmaceuticals, Inc.", "longName": "ARS Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 1668004200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "d8a743bf-b873-3187-ac17-afe99130ffb3", "messageBoardId": "finmb_585213447", "gmtOffSetMilliseconds": -14400000, "currentPrice": 9.47, "targetHighPrice": 19.0, "targetLowPrice": 19.0, "targetMeanPrice": 19.0, "targetMedianPrice": 19.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 228360000, "totalCashPerShare": 2.366, "ebitda": -67447000, "totalDebt": 274000, "quickRatio": 95.841, "currentRatio": 96.916, "totalRevenue": 30000, "debtToEquity": 0.119, "returnOnAssets": -0.16399999, "returnOnEquity": -0.21589, "freeCashflow": -36174000, "operatingCashflow": -59266000, "operatingMargins": -2250.6667, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-02"}]